What is VIZIMPRO?

• As your first treatment if your tumor has certain types of abnormal epidermal growth factor receptor (EGFR) gene(s).

Before taking VIZIMPRO, tell your healthcare provider about all your medical conditions, including if you:

• have frequent diarrhea.
• have a history of lung or breathing problems other than lung cancer.
• are pregnant, or plan to become pregnant. VIZIMPRO can harm your unborn baby.

Females who are able to become pregnant:

 

• Your healthcare provider should do a pregnancy test before you start treatment with VIZIMPRO.
• You should use effective birth control (contraception) during treatment and for at least 17 days after your last dose of VIZIMPRO. Talk to your healthcare provider about birth control methods that may be right for you during this time.
• Tell your healthcare provider right away if you become pregnant during your treatment with VIZIMPRO.

• are breastfeeding or plan to breastfeed. It is not known if VIZIMPRO passes into your breast milk. Do not breastfeed during treatment and for at least 17 days after your last dose of VIZIMPRO. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VIZIMPRO and other medicines or supplements may affect each other causing side effects.